Invesco
MTEM

Invesco’s Molecular Templates, Inc. MTEM Stock Holding History

Invesco’s Portfolio MTEM Stock Details MTEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-920
Closed -$48K – 4191
2022
Q1 		$48K Buy
920
+7
+0.8% +$309 ﹤0.01% 3934
2021
Q4 		$54K Sell
913
-170
-16% -$12.7K ﹤0.01% 3973
2021
Q3 		$109K Buy
1,083
+218
+25% +$22.5K ﹤0.01% 3924
2021
Q2 		$101K Buy
+865
New +$113K ﹤0.01% 3893
2020
Q4 		– Sell
-6,113
Closed -$1M – 3845
2020
Q3 		$1M Buy
6,113
+5,048
+474% +$897K ﹤0.01% 2823
2020
Q2 		$220K Sell
1,065
-4,022
-79% -$934K ﹤0.01% 3447
2020
Q1 		$1.01M Sell
5,087
-1,047
-17% -$229K ﹤0.01% 2715
2019
Q4 		$1.29M Buy
+6,134
New +$882K ﹤0.01% 2862
2015
Q3 		– Sell
-8
Closed -$5K – 4052
2015
Q2 		$5K Buy
+8
New +$5.29K ﹤0.01% 4232
2013
Q3 		– Sell
-42
Closed -$36K – 4349
2013
Q2 		$36K Buy
+42
New +$35.5K ﹤0.01% 4084

Other funds holding MTEM

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Invesco's MTEM Position: Q2 2022 in Review

Invesco sold out of Molecular Templates, Inc. (MTEM) in Q2 2022, closing a stake of 920 shares — an estimated $48K sold.

Invesco first reported a position in MTEM in Q2 2013 and held it in 10 quarters. The position peaked at $1.29M in Q4 2019. 65 funds tracked by Wall St. Rank hold MTEM as of Q2 2022.

  • Invesco reported no remaining Molecular Templates, Inc. position as of Q2 2022 after selling out during the quarter.
  • Invesco sold 920 Molecular Templates, Inc. shares in Q2 2022, an estimated $48K.
  • Invesco first reported a position in Molecular Templates, Inc. in Q2 2013 and held it in 10 quarters.
  • Invesco's Molecular Templates, Inc. position peaked at $1.29M in Q4 2019.
  • 65 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q2 2022.

Based on Invesco's 13F filing for Q2 2022, filed 15 Aug 2022.